Incision
Surgical information-sharing and education platform
- 101-200 employees
- Healthcare
- B2B
- Sharing Economy
- Learning
- MedTech
- Oostenburg, Amsterdam, Netherlands
Jump to section
Company mission
To share surgical skills and make high quality surgical knowledge accessible to everyone. That’s why we created Incision — to enable continuous surgical improvement that leads to better outcomes for everyone.
Our take
Surgery makes up a big chunk of hospital budgets, and has a massive role in clinical outcomes for patients. Despite this, surgery tends to differ considerably between hospitals. Differences in factors like technique, post-surgery care and even operating room efficiency have led to a low level of standardisation, and as a result, surgery across the globe is failing to be optimised to its full potential.
Incision has set out to fix this. By building a knowledge platform based around surgery, it is improving surgical practices worldwide by allowing practitioners to share experiences, skills and expertise. As well as this, Incision offers new educational products and services ranging from 3D anatomy models to AI-driven video analysis of surgical performance. Going forward, this diversity of output will be a big advantage for Incision.
With an estimated 1.2 million practicing surgeons worldwide, Incision's potential market is big and getting bigger. Its international strategy - based on building presence in a number of key markets - has been bolstered by funding, and Incision remains focused on expansion into the UK, Scandinavia, the Middle East, and Belgium. The company's goal is to impact 100 million procedures each year by 2030.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Market standard package for a scale-up environment based on your experience
Company values
- We're on a mission to make a real impact, and our passion fuels every step of the journey
- Excellence is not just a goal; it's our commitment to delivering the best in healthcare
- Innovation is our driving force, and change is the canvas upon which we paint new possibilities
Funding (2 rounds)
Nov 2023
$7m
SERIES B
May 2021
$5.3m
SERIES A
Total funding: $12.3m
Leadership
Theo Wiggers
(Medical Director & Co-Founder)A doctor of medicine and ex-professor at University Medical Center Groningen.